https://www.selleckchem.com/pr....oducts/pim447-lgh447
11 (0.93, 1.32) for ischaemic stroke or systemic thromboembolism, 1.26 (1.09, 1.46) for major bleeding, and 1.17 (1.05, 1.3 for the composite endpoint. For apixaban vs dabigatran, they were 0.91 (0.74, 1.12) for ischaemic stroke or systemic thromboembolism, 0.89 (0.75, 1.05) for major bleeding, and 0.94 (0.78 to 1.14) for the composite endpoint. For apixaban vs rivaroxaban, they were 0.85 (0.74, 0.99) for ischaemic stroke or systemic thromboembolism, 0.61 (0.53, 0.7 for major bleeding, and 0.82 (0.76, 0.88) for the composite e
Like
Comment
Share
